Instead, administration of Bryostatin 1 worsened cognitive symptoms of the treated AD patients (https://clinicaltrials.gov/ct2/show/results/NCT02221947?term=PKC%2C+alzheimer&draw=1&rank=1). The gene discussed is PRRT2; the disease is Alzheimer disease.